C41h43n3O9 Cytidine, N-Benzoyl-5'-O- 4-Athoxyphenyl) -2'-O- (2CI, ACI) H335, H319, H319, H319, H319, H319, H319, H319

SMILSICAL CLAMES O = C1N = C (NC (= O) C = CC2) C (CC = CC = CC = CC = CC = c6) C = c6) c
Ataata isomeric
C (oc [c @ h] 1o [c @ h] (cc = cc = c4 = cc = cc = cc = cc = cc = cc = cc = cc = c
Hapani
Inchi = 1s / C41H43N3O9 / C1-27-25-44 (40 (47) 43-37 (46) 282-38 (46)
-9-6-10-10-14-29,30-15-19-19-19 (49-3) 20-16-30) 31-17-30)
Inchi Key
Byscluikfefah-lzurgkrnsa-n
23 etahi atu ingoa mo tenei taonga
N-Benzoyl-5'-o- BIS (4-athoxyphenyl) phenylmethyl] -2''-o- 10: PN: PN: WO0308478 Whārangi: 57 I kii a RNA; 12: PN: US20030170636 Whārangi: 17 I kii a n; 13: PN: US200302121717 Whārangi: 19 I kii a R N; 14: PN: US20030

211606 Whārangi: 19 kereme r na; 15: PN: US20040005569 Whārangi: 22 I kii a R N; 16: PN: US20040006030 Whārangi: 22 kereme r na; 16: PN: US2004001484 Whārangi: 20 I kii r NO; 17: PN: US2003017133 Whārangi: 9 I kii a n; 17: PN: US20040005565 Whārangi: 17- 22 I kii a RNA; 17: PN: US20040005570 Whārangi: 20 I kii r NO; 17: PN: US2004001474 Whārangi: 20 I kii r NA; 17: PN: US20040 014050 Whārangi: 20 kereme r na; 18: PN: US200301975 Whārangi: 19 I kii a R N; 18: PN: US20040014699 Whārangi: 20 i kii r na na; 19: PN: US20040006029 Whārangi: 23 I kii a NA; 19: PN: PN: WO0310645 Whārangi: 71 I kii a na; 59: PN: US20030166592 Whārangi: 15 I kii a RNA; 6: PN: WO200500658 Whārangi: 62 I kii a n; 83: PN: US200401717176 Whārangi: 18 I kii a R N; 8: PN: WO2005007825
Whārangi: 62 i kii r na; 90: PN: US20040005707 Whārangi: 20 I kii r NA; N4-Benzoyl-2'-o-o-meTooxyethyl-5'-o-o-dimethoxytrityl-5-
methylcytidine